ArticleFocus (American Psychiatric Publishing)2025
Advocacy and the Opioid Epidemic: Positioning Providers to Influence Policy and Improve Public Health.
Article in Focus (American Psychiatric Publishing), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2024, for the first time in more than a decade, the year-over-year rate of American opioid overdose deaths demonstrated a sustained downward trend. Years of public policy interventions that changed clinical practice, shaped population-level behaviors, and enacted measures to prevent overdoses finally prevailed. Advocacy from behavioral health professionals has been central to this milestone, which inspires a call to action for increased professional advocacy moving forward, yet research indicates that many practitioners do not feel empowered to engage in advocacy because they lack familiarity with the process. With limited training programs in advocacy, this article attempts to fill the gap, examining effective policy advocacy related to opioids and other substances, the role behavioral health professionals have played in successful policy changes, suggestions for integrating advocacy practice into clinical training programs, and guidelines for professionals to promote advocacy at local, regional, and national levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.